<乌鸦传媒>Novel Drug Maintained Clinical Improvements in IBD Greater benefit seen with higher dose of tulisokibart at week 50 Oct 16, 2024
<乌鸦传媒>Allele May Heighten Risk of Severe Ulcerative Colitis Finding on HLA-DRB1*01:03 supports need for more and earlier genetic studies Oct 15, 2024
<乌鸦传媒>Placebos Linked to Potential Harms in IBD Clinical Trials Alternative designs needed, researchers caution Sep 26, 2024
<乌鸦传媒>Novel Monoclonal Antibody Shows Promise in Ulcerative Colitis 26% of patients receiving tulisokibart achieved clinical remission vs 1% with placebo Sep 25, 2024
<乌鸦传媒>FDA Expands Approval of IL-23 Drug to Ulcerative Colitis In trials, guselkumab more than doubled remission rates versus placebo Sep 12, 2024
<乌鸦传媒>Should Intensified Infliximab for Refractory Acute Severe UC Be Nixed? PREDICT-UC trial found no benefit with intensified or accelerated regimens Sep 06, 2024
<乌鸦传媒>PBMs Are Stacking the Deck Against Patients and Independent Physician Practices Infusion services and other therapies must be delivered without delay Aug 11, 2024
Industry Clinic 鈥� Ad Insights <乌鸦传媒>Our Understanding of IBD Has Come a Long Way—So Have the Options to Treat It Aug 02, 2024
<乌鸦传媒>Can App Data Link Sleep and Chronic Disease?; AI Model to Manage Diabetes Also in TTHealthWatch: a monoclonal antibody for ulcerative colitis Jul 27, 2024 podcast
<乌鸦传媒>Humira Clobbers Biosimilars in Battle for Part D Coverage Pricing, payer policies keep market leader on top Jun 06, 2024
<乌鸦传媒>Guselkumab Continues Winning Streak in Crohn's Disease Dual-acting IL-23 inhibitor tops placebo, ustekinumab in phase III trials May 22, 2024
<乌鸦传媒>Healthcare Use Reduced When Female Gastroenterologists See Patients Female patients appeared to derive the greatest benefit, researchers say May 21, 2024
<乌鸦传媒>Rare Pregnancy Problem Linked to Thiopurines, FDA Says Agency finds risk for intrahepatic cholestasis of pregnancy mostly in IBD, lupus patients May 03, 2024
<乌鸦传媒>Loss of Anti-TNF Treatment Response Common in Crohn's Disease Study identified factors and strategies for maintaining response Apr 22, 2024
<乌鸦传媒>TNF Inhibitors for IBD Linked to Kidney Function Declines Observational VA data support recommendations for monitoring with initiation Apr 16, 2024
<乌鸦传媒>Can an Autoimmunity Lead to Immune Deficiency? Studies may explain some cases of rare opportunistic infections Mar 20, 2024
<乌鸦传媒>Valley Fever Screens Found Lagging for Rheum Patients in Endemic Areas A significant issue for DMARD and steroid users in the American Southwest Mar 14, 2024
<乌鸦传媒>Risankizumab Beats Ustekinumab for Previously Treated Crohn's The IL-23 inhibitor led to more clinical remissions vs the IL-12/23 inhibitor Feb 26, 2024
<乌鸦传媒>Top-Down Treatment Superior to Step-Up Approach for Crohn's Disease Early intensive treatment should be standard for most patients, researchers argue Feb 26, 2024
<乌鸦传媒>AGA Backs Fecal Microbiota-Based Therapies for Recurrent C. Diff But new guidelines do not recommend use in inflammatory bowel disease or irritable bowel syndrome Feb 21, 2024
<乌鸦传媒>Dose Escalation With Infliximab Biosimilar Can Restore Responses in IBD Patients with ulcerative colitis and Crohn's also experienced improved clinical remission Feb 02, 2024
<乌鸦传媒>History of IBD Linked to Severe Outcomes in Patients Hospitalized for COVID IBD was associated with an increased risk of sepsis, shock, and acute kidney injury Feb 01, 2024
<乌鸦传媒>IBD Surgery Linked to Improved Patient-Reported Pain, Physical Health However, this was not the case for social, emotional outcomes Jan 31, 2024
<乌鸦传媒>Telehealth Option Increased IBD Clinic's Patient Retention More than 60% of patients had return IBD care delivered via telehealth Jan 30, 2024
<乌鸦传媒>Switching Twice With Infliximab Biosimilars Not Linked With IBD Flare Risk Reassuring findings for patients whose insurance requires a switch Jan 28, 2024
<乌鸦传媒>Early Anti-TNF Reduces Perianal Fistula Risk in Kids With Crohn's "Far better to prevent these complications than to treat them once they occur," says researcher Jan 28, 2024
<乌鸦传媒>Clinical Challenges: Integrating Diet Into Crohn's Disease Management Whole-foods dietary patterns should complement therapeutic regimens Dec 27, 2023
<乌鸦传媒>Ozanimod Did Not Appear to Lead to More Adverse Pregnancy Outcomes However, avoiding pregnancy when on the IBD/MS drug still advised Dec 19, 2023
<乌鸦传媒>Novel Oral Agent May Dial Down Ulcerative Colitis Severity Investigational drug missed primary endpoint, but yielded durable responses in early trial Dec 18, 2023
<乌鸦传媒>Shingles Vaccine Reduced Zoster Attacks in Patients With IBD Patients 50 and older saw benefits with vaccine, except in cases of complicated zoster Dec 18, 2023
<乌鸦传媒>Goodbye, Appendix. Hello, Crohn's Disease? Meta-analysis finds a possible connection, although high heterogeneity was an issue Dec 17, 2023
<乌鸦传媒>Red Meat Consumption Tied to Higher Chance of UC Flare But similar association not seen for other high fat foods Dec 17, 2023
<乌鸦传媒>National Database Study Finds Higher Risk for Barrett鈥檚 Esophagus in IBD But no greater chance of BE-tied malignancy for these patients Dec 16, 2023
<乌鸦传媒>Methotrexate Tied to Greater Risks for Older Patients With CKD FDA should consider warning labels based on study results, researchers argue Nov 28, 2023
<乌鸦传媒>Biologic Therapy for IBD Not Tied to Higher Risk of Major Heart Events Newer agents also associated with lower VTE risk versus non-advanced treatments Nov 28, 2023 video
<乌鸦传媒>How to Position the Growing Number of Therapies in IBD "Exciting time" to treat Crohn's disease and ulcerative colitis, expert says Nov 21, 2023 video
<乌鸦传媒>New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks More than half of patients not in early clinical response at week 12 responded by week 24 Nov 14, 2023 video
<乌鸦传媒>Stelara Biosimilar OK'd With Interchangeability But patent settlement may keep new product off market until 2025 Nov 01, 2023
<乌鸦传媒>Controversial Kratom Appeared to Cause Severe Ulcerative Colitis Flare Researchers strongly discourage its use in IBD patients Oct 24, 2023
